References
- Tanumihardjo SA, Russell RM, Stephensen CB, et al. Biomarkers of nutrition for development (BOND) – vitamin A review. J Nutr. 2016;146:1816S–1848S.
- Ono K, Yamada M. Vitamin A and Alzheimer’s disease. Geriatr Gerontol Int. 2012;12:180–188.
- Shearer KD, Stoney PN, Morgan PJ, McCaffery PJ. A vitamin for the brain. Trends Neurosci. 2012;35:733–741.
- Chávez CJ, Ortega P, Leal J, et al. Deficiencia de vitamina A y estado nutricional en pacientes con Síndrome de Down. Anales De Pediatría. 2010;72:185–190.
- Lee HP, Casadesus G, Zhu X, et al. All-trans retinoic acid as a novel therapeutic strategy for Alzheimer’s disease. Expert Rev Neurother. 2009;9:1615–1621.
- Das BC, Thapa P, Karki R, et al. Retinoic acid signaling pathways in development and diseases. Bioorg Med Chem. 2014;22:673–683.
- Jacobs S, DeCicco KL, Shi Y, et al. Retinoic acid is required early during adult neurogenesis in the dentate gyrus. PNAS. 2006; 103:3902–3907.
- Connolly RM, Nguyen NK, Sukumar S. Molecular pathways: current role and future directions of the retinoic acid pathway in cancer prevention and treatment. Clin Cancer Res. 2013;19:1651–1659.
- Blomhoff R, Blomhoff HK. Overview of retinoid metabolism and function. J Neurobiol. 2006;66:606–630.
- Doldo E, Costanza G, Agostinelli S, et al. Vitamin A, cancer treatment and prevention: the new role of cellular retinol binding proteins. BioMed Res Int. 2015;2015:1–14.
- Berdanier CD, Christina Hermoyian HBE, Mathews CE. Role of vitamin A in mitochondrial gene expression. Diab Res Clin Pract. 2001;54:11–27.
- de Oliveira MR. Vitamin A and retinoids as mitochondrial toxicants. Oxid Med Cell Longev. 2015;2015:140267.
- Tripathy S, Chapman JD, Han CY, et al. All-trans-retinoic acid enhances mitochondrial function in models of human liver. Mol Pharmacol. 2016;89:560–574.
- HroudováJ, Singh N, Fišar Z. Mitochondrial dysfunctions in neurodegenerative diseases: relevance to Alzheimer’s disease. BioMed Res Int. 2014;2014:1–9.
- Izzo A, Nitti M, Mollo N, et al. Metformin restores the mitochondrial network and reverses mitochondrial dysfunction in Down syndrome cells. Hum Mol Genet. 2017;26:1056–1069.
- Helguera P, Seiglie J, Rodriguez J, et al. Adaptive downregulation of mitochondrial function in down syndrome. Cell Metabol. 2013; 17:132–140.
- Izzo A, Manco R, Bonfiglio F, et al. NRIP1/RIP140 siRNA-mediated attenuation counteracts mitochondrial dysfunction in Down syndrome. Hum Mol Genet. 2014;23:4406–4419.
- Piccoli C, Izzo A, Scrima R, et al. Chronic pro-oxidative state and mitochondrial dysfunctions are more pronounced in fibroblasts from Down syndrome foeti with congenital heart defects. Hum Mol Genet. 2013;22:1218–1232.
- Cui L, Jeong H, Borovecki F, et al. Transcriptional repression of PGC-1alpha by mutant Huntingtin leads to mitochondrial dysfunction and neurodegeneration. Cell. 2006;127:59–69.
- Hondares E, Mora O, Yubero P, et al. Thiazolidinediones and rexinoids induce peroxisome proliferator-activated receptor-coactivator (PGC)-1alpha gene transcription: an autoregulatory loop controls PGC-1alpha expression in adipocytes via peroxisome proliferator-activated receptor-gamma coactivation. Endocrinology. 2006;147:2829–2838.
- Garcia-Rojas P, Antaramian A, Gonzalez-Davalos L, et al. Induction of peroxisomal proliferator-activated receptor and peroxisomal proliferator-activated receptor coactivator 1 by unsaturated fatty acids, retinoic acid, and carotenoids in preadipocytes obtained from bovine white adipose tissue1,2. J Anim Sci. 2010;88: 1801–1808.
- Feng X, Yu W, Liang R, et al. Receptor-interacting protein 140 overexpression promotes neuro-2a neuronal differentiation by ERK1/2 signaling. Chin Med J. 2015;128:119–124.
- Zhao ZR, Yu WD, Shi C, et al. Correlation between receptor-interacting protein 140 expression and directed differentiation of human embryonic stem cells into neural stem cells. Neural Regen Res. 2017;12:118–124.
- Heim KC, Gamsby JJ, Hever MP, et al. Retinoic acid mediates long-paced oscillations in retinoid receptor activity: evidence for a potential role for RIP140. PLoS ONE. 2009;4:e7639.
- Wu CY, Feng X, Wei LN. Coordinated repressive chromatin-remodeling of Oct4 and Nanog genes in RA-induced differentiation of embryonic stem cells involves RIP140. Nucleic Acids Res. 2014;42: 4306–4317.
- Christian M, White R, Parker MG. Metabolic regulation by the nuclear receptor corepressor RIP140. Trends Endocrinol Metab. 2006;17:243–250.
- Blondrath K, Steel JH, Katsouri L, et al. The nuclear cofactor receptor interacting protein-140 (RIP140) regulates the expression of genes involved in Abeta generation. Neurobiol Aging. 2016;47:180–191.
- Riddoch FC, Brown AM, Rowbotham SE, et al. Changes in functional properties of the caffeine-sensitive Ca2+ store during differentiation of human SH-SY5Y neuroblastoma cells. Cell Calcium. 2007;41:195–206.
- Ferrari-Toninelli G, Bonini SA, Uberti D, et al. Targeting notch pathway induces growth inhibition and differentiation of neuroblastoma cells. Neuro-Oncology. 2010;12:1231–1243.
- Asson-Batres MA, Rochette-Egly C, editors. The biochemistry of retinoic acid receptors I: structure, activation, and function at the molecular level. Vol. 70. Dordrech, Netherlands: Springer; 2014.
- Lopez-Lluch G, Irusta PM, Navas P, de Cabo R. Mitochondrial biogenesis and healthy aging. Exp Gerontol. 2008;43:813–819.
- Chen Y, Wang Y, Chen J, et al. Roles of transcriptional corepressor RIP140 and coactivator PGC-1alpha in energy state of chronically infarcted rat hearts and mitochondrial function of cardiomyocytes. Mol Cell Endocrinol. 2012;362:11–18.